Recital 2, Regulation (EU) 2021/2047

In forcesince 23 Nov 2021

In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of amprolium hydrochloride (COXAM). That application was accompanied by the particulars and documents required under Article 7(3) of that Regulation.